Choose your location
Singapore
English
Belgium
Denmark
Estonia
Finland
France
Iceland
Ireland
Latvia
Lithuania
Luxembourg
Netherlands
Norway
Portugal
Sweden
United Kingdom
Holistic approach to China equity investing
- Seek attractive investment opportunities across Chinese companies listed both onshore and offshore, including A shares, H shares, ADR (American Depositary Receipt)
- Being benchmark-unconstrained, the fund manager takes a truly active approach
Investing in change
- Identify change in business fundamentals or investor behaviour
- We believe mispricing could arise in areas where future fundamentals will be different from the past
Looking beyond the obvious
- The team seeks to go beyond the top 100 mega-cap names1 and focus on the less efficient part of the market
- The fund manager looks for opportunities across small, mid and large cap companies
¹ Source: MSCI, FactSet. Financial data and analytics provider FactSet. Copyright 2023 FactSet. All Rights Reserved. As of 31 March 2023. The top mega-cap names and market cap cut-off could evolve with changing market dynamics over time.
China Evolution Equity Fund
Class A
Inception Date
10 August 2020
Base currency
USD
Management Fee
Up to 1.70% p.a.
ISIN code
LU2187417386
Bloomberg code
TCEEAUI LX
Benchmark
MSCI China All Shares Index Net
Full details of the fees payable by investors are available within the prospectus.
This benchmark is shown for comparison purposes only.
Additional Disclosures
MSCI and its affiliates and third party sources and providers (collectively, “MSCI”) makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, reviewed, or produced by MSCI. Historical MSCI data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. None of the MSCI data is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such.
Important Information
Unless otherwise stated, all data is as of 30 September 2023 and sourced from T. Rowe Price. Certain numbers in this website may not add due to rounding and/or the exclusion of cash.
Investment involves risk. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can fall as well as rise. You may get back less than the amounted invested. The performance returns are denominated in the share class dealing currency which can be a foreign currency and if so, US/SG dollar-based investors are exposed to fluctuations in the US/SG dollar/foreign currency exchange rate. Before deciding to invest in the fund, you should read the offering document/prospectus (including its investment objectives, policies and any risk warnings) and the product highlights sheet which are available and may be obtained from any appointed distributors.
T. Rowe Price Singapore Private Ltd. is the appointed Singapore representative and agent for service of process in Singapore. SICAV refers to the T. Rowe Price Funds SICAV, a Luxembourg investment company with variable capital which is registered with Commission de Surveillance du Secteur Financier and which qualifies as an undertaking for collective investment in transferable securities (“UCITS”).
202310-3159459